missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human IL-29/IFN-lambda 1 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
POA
Specifications
Gene ID (Entrez) | 282618 |
---|---|
Molecular Weight (g/mol) | 21.4 kDa |
Name | IL-29/IFN-lambda 1 |
Quantity | 25μg |
Source | Mouse myeloma cell line,NS0-derived human IL-29/IFN-lambda 1 protein Gly20-Thr200,with a C-terminal 10-His tag |
Description
The Recombinant Human IL-29/IFN-lambda 1 Protein is derived from NS0. The Recombinant Human IL-29/IFN-lambda 1 Protein has been validated for the following applications: Bioactivity.Specifications
282618 | |
IL-29/IFN-lambda 1 | |
Mouse myeloma cell line,NS0-derived human IL-29/IFN-lambda 1 protein Gly20-Thr200,with a C-terminal 10-His tag | |
Unconjugated |
21.4 kDa | |
25μg | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
Recombinant |